Open access
Open access
Powered by Google Translator Translator

Randomized Trial: Treatments for HPV-Positive Throat Cancer Compared

30 Nov, 2018 | 01:29h | UTC

Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial – The Lancet (free)

Commentaries: De-intensified treatment in human papillomavirus-positive oropharyngeal cancer – The Lancet (free) AND Standard chemotherapy treatment for HPV-positive throat cancer remains the most effective, study finds – University of Birmingham (free)

 


Stay Updated in Your Specialty

 

No spam, just news.